论文部分内容阅读
胎肝细胞悬液(FLC)输注治疗再生障碍性贫血(再障)已有较多报导,近来有作者报告胎肝无细胞悬液(FLCF)亦有效。本文报告16例再障FLCF输注治疗结果。一、材料与方法:①病例:均为原发性再障;急性再障2例,慢性再障14例,病程1月～10年;骨髓均增生减低,其中3例做3GM-CFU,结果明显低于正常。③FLCF的制备:中期水囊引产胎儿(3～6.5月)娩出后-20~C冰箱保存24～48小时,室温下溶化无菌下取出肝脏用蒸馏水制成悬液70ml,4℃冰箱保存3小时,加3％NaCl30ml即为等渗
Fetal liver cell suspension (FLC) infusion treatment of aplastic anemia (aplastic anemia) has been more reported, the recent report of fetal liver cell free suspension (FLCF) is also effective. This article reports 16 cases of aplastic anemia FLCF infusion treatment results. First, materials and methods: ① cases: primary aplastic anemia; 2 cases of acute aplastic anemia, chronic aplasia in 14 cases, duration of 1 months to 10 years; bone marrow hyperplasia decreased, of which 3 cases do 3GM-CFU, the results Obviously lower than normal. ③ FLCF preparation: mid-term induced abortion fetus fetus (3-6.5 months) after delivery -20 ~ C refrigerator to save 24 to 48 hours, dissolved under sterile aurora at room temperature to remove the liver made of distilled water suspension 70ml, 4 ℃ refrigerator for 3 hours , Plus 3% NaCl30ml is isotonic